Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.
about
Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessingPathobiology of the stratum corneum.Connexin 26 regulates epidermal barrier and wound remodeling and promotes psoriasiform response.Barrier requirements as the evolutionary "driver" of epidermal pigmentation in humansMechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitisUltrasound-enhanced transdermal delivery: recent advances and future challengesCholinergic regulation of keratinocyte innate immunity and permeability barrier integrity: new perspectives in epidermal immunity and diseaseCloning of murine translation initiation factor 6 and functional analysis of the homologous sequence YPR016c in Saccharomyces cerevisiae.Expression of the C-C chemokine MIP-3 alpha/CCL20 in human epidermis with impaired permeability barrier functionPseudo-acylceramide with linoleic acid produces selective recovery of diminished cutaneous barrier function in essential fatty acid-deficient rats and has an inhibitory effect on epidermal hyperplasiaThe use of a semiocclusive dressing reduces epidermal inflammatory cytokine expression and mitigates dermal proliferation and inflammation in a rat incisional modelKeratin 16 regulates innate immunity in response to epidermal barrier breachEvidence that stress to the epidermal barrier influenced the development of pigmentation in humansPsychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice.Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation.External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriersWounding-induced synthesis of hyaluronic acid in organotypic epidermal cultures requires the release of heparin-binding egf and activation of the EGFRThe pathogenic role of interleukin-22 and its receptor during UVB-induced skin inflammation.Maintenance of peripheral tolerance through controlled tissue homing of antigen-specific T cells in K14-mOVA mice.Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin.Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasisEndotoxin increases parathyroid hormone-related protein mRNA levels in mouse spleen. Mediation by tumor necrosis factorEpidermal cytokines in murine cutaneous irritant responses.Langerhans cells as targets for immunotherapy against skin cancer.Malnutrition-associated rash of cystic fibrosis.Functional characterization of cultured keratinocytes after acute cutaneous burn injury.Abnormal epidermal barrier recovery in uninvolved skin supports the notion of an epidermal pathogenesis of psoriasisTranscutaneous immunization system using a hydrotropic formulation induces a potent antigen-specific antibody response.Local burn injury impairs epithelial permeability and antimicrobial peptide barrier function in distal unburned skinTopically applied ZnO nanoparticles suppress allergen induced skin inflammation but induce vigorous IgE production in the atopic dermatitis mouse model.Epidermal barrier formation and recovery in skin disorders.Irritant dermatitis, irritancy and its role in allergic contact dermatitis.IL-2, IL-5, TNF-α and IFN-γ mRNA expression in epidermal keratinocytes of systemic lupus erythematosus skin lesionsThematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis.Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis.Epidermal keratinocytes initiate wound healing and pro-inflammatory immune responses following percutaneous schistosome infectionInhibition of keratinocyte differentiation by the synergistic effect of IL-17A, IL-22, IL-1α, TNFα and oncostatin M.Skin barrier disruption: a requirement for allergen sensitization?The role of innate immune signaling in the pathogenesis of atopic dermatitis and consequences for treatments.Nrf2 links epidermal barrier function with antioxidant defense
P2860
Q24300787-93601E57-AF66-44B0-B8F5-8A1F8E25C291Q24539142-36B59004-C3BB-4514-B987-3EC8FF4EEA4AQ24543614-4AAC89B3-29BF-4B6D-A893-84B18ACD8A4AQ24624475-4E273BF8-FCA8-4A04-966A-2144416DB414Q26827984-A5053206-F8CF-402A-B64E-756D3EB4B99FQ26829601-1122A125-D0E2-4B46-AD67-7BF565232274Q26998399-7311FC06-AE1A-470D-A659-F1DE5CE441B4Q27939400-30DF0843-766E-4384-AF64-57186C172C28Q28216686-B770165D-278E-419F-8E6B-C97AB45DE660Q28369339-6C354D6D-D82E-41AB-BCCC-280E9FD622E4Q28567986-6E9C01FE-C765-4FBF-8C88-D5390AEC61EBQ28592667-93A624F7-FBB0-4183-8466-2A472C496E80Q28748361-47B41351-25E9-4C0B-A2B4-32D7F6E255ADQ30480323-F29635EB-5308-4C5E-9191-FC64CB548258Q30515730-9388E1EC-0FB0-474D-8055-6916E1BEC3E9Q33590480-2F1C67B0-9F00-4576-B335-EFF82A4D5B1CQ33610372-CD69BC38-A9DC-409F-9D48-67F008B3CBCBQ33739315-2A0D2BA0-514E-48A7-A8B1-4A252EF9D04AQ33747003-8BF0B8F4-B261-418E-917E-C9E27D8EDB2FQ33805053-011ADF94-21DA-4D59-BE8E-E70B1A4784F9Q33901930-F8B85852-AA9A-4809-8EA7-4B9032C43C83Q33909101-6EABD8F6-E0D8-485E-AF6E-A911CD1BB495Q34003185-06D14DB7-C4D7-45C3-8E49-B7962C1031EFQ34009436-768F358A-61E3-45FC-A4A2-6897C5AF3B77Q34086280-D6E5970F-6CA2-4D2A-993F-1D3D01279121Q34168004-17DF03ED-9B20-4CF8-A3E9-56F5423D5356Q34353182-FF4C3B72-8409-41D0-8230-16487BA2B47CQ34460808-6571FB41-FB10-4E05-B742-BFA91C79EBE3Q34510667-347E0F50-D1A3-4FA1-BD9B-55C2F8528156Q34545287-C8365BDD-45F8-4608-BA10-E2D0FA371B24Q34576611-1F286F52-BC1F-47D5-B50F-A9495332D391Q34600605-D64D8249-5288-494F-8ED9-F8BD428F7DC3Q34604047-8D095D51-A46C-4CA0-A486-1DD7F80EB30CQ34687966-D17E1598-FD57-4D22-9721-06B5CF5FF221Q34797596-D6BD0FCC-3B30-4636-9E3B-62D5678C1163Q35195110-22C65D1A-CCCA-4CB4-8AAC-CED257968FEFQ35204519-FB09235A-CEE0-42CE-8D46-D5F8C36A87AEQ35757285-AFBF5C79-78E3-4BFA-BC3C-7471553F584FQ35842929-4A27302D-F4F8-4A32-AC49-F792D8DA8EA0Q36111346-88AD333E-F047-42C4-9C86-37DD4437F9D8
P2860
Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.
@ast
Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.
@en
type
label
Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.
@ast
Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.
@en
prefLabel
Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.
@ast
Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.
@en
P2093
P2860
P356
P1476
Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.
@en
P2093
C Grunfeld
K R Feingold
S M Jackson
P2860
P304
P356
10.1172/JCI115884
P407
P577
1992-08-01T00:00:00Z